SCHEMBL18784244

SCHEMBL18784244

NCCNc1cc(CS(=O)(=O)c2ccccc2)ccc1-c1ccoc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.40
PTGES2 Q9H7Z7 1/20 0.38
NAT1 P18440 2/20 0.36
MAPT P10636 1/20 0.34
PLAU P00749 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HSD17B10 Q99714 3/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CLK4 Q9HAZ1 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
KMT2A Q03164 1/20 0.34
TSHR P16473 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18784231 0.79 CSNK2A1 (0.41) CSNK2A1PTGES2NAT1MAPTPLAU
SCHEMBL18784242 0.78 CSNK2A1 (0.40) CSNK2A1PTGES2NAT1MAPTPLAU
SCHEMBL18784223 0.77 CSNK2A1 (0.39) CSNK2A1PTGES2NAT1MAPTPLAU
SCHEMBL18784245 0.77 NAT1 (0.39) CSNK2A1PTGES2NAT1MAPTPLAU
SCHEMBL14725678 0.76 NAT1 (0.36) CSNK2A1PTGES2NAT1PLAUHSD17B10
Hydrochloric Acid SCHEMBL1647973 0.76 NAT1 (0.36) CSNK2A1PTGES2NAT1PLAUHSD17B10
SCHEMBL18784252 0.74 KDM4E (0.41) CSNK2A1NAT1ALDH1A1LMNAHTR6
SCHEMBL18784214 0.72 CSNK2A1 (0.36) CSNK2A1PTGES2NAT1MAPTCYP1A2
Hydrochloric Acid SCHEMBL1648354 0.70 NAT1 (0.33) NAT1MAPTHSD17B10TSHRSMN1; SMN2
SCHEMBL18784246 0.69 HTR7 (0.43) CSNK2A1ALDH1A1SMN1; SMN2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP claimed